Blood lipid and hematoma enlargement and outcome in patients with intracerebral hemorrhage
10.3760/cma.j.issn.1673-4165.2022.11.010
- VernacularTitle:血脂与脑出血患者的血肿增大和转归
- Author:
Ting LAN
1
;
Wensi ZHANG
;
Jingfen ZHANG
Author Information
1. 内蒙古医科大学包头临床医学院，包头市中心医院神经内科 014040
- Keywords:
Cerebral hemorrhage;
Hematoma;
Lipids;
Cholesterol;
Cholesterol, LDL;
Cholesterol, HDL;
Hydroxymethylglutaryl-CoA reductase inhibitors;
Treatment outcome
- From:
International Journal of Cerebrovascular Diseases
2022;30(11):849-853
- CountryChina
- Language:Chinese
-
Abstract:
Early hematoma enlargement is one of the main factors of early neurological deterioration in patients with intracerebral hemorrhage. The correlation between blood lipid and hematoma enlargement is a research hotspot at present. This article reviews the relationship between blood lipid and hematoma enlargement and outcomes in patients with intracerebral hemorrhage, as well as the correlation between statin treatment and hematoma enlargement.
